Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Zvelebil

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Idrugs : the Investigational Drugs Journal|May 10, 2008
Flavopiridol Hoechst AGM J Zvelebil
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prediction of protein structure from sequenceM J Sternberg, M J Zvelebil
Quarterly Reviews of Biophysics|August 1, 1993
Peptide-protein interactions: an overviewM J Zvelebil, J M Thornton
Protein Engineering|July 1, 1988
Analysis and prediction of the location of catalytic residues in enzymesM J Zvelebil, M J Sternberg
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
A detailed molecular model for human aromataseC A Laughton, M J Zvelebil, S Neidle
European Journal of Biochemistry|April 1, 1994
Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicalsM L Cunningham, M J Zvelebil, A H Fairlamb
Protein Engineering|February 1, 1991
A predicted three-dimensional structure of human cytochrome P450: implications for substrate specificityM J Zvelebil, C R Wolf, M J Sternberg
Protein Engineering|June 1, 1995
Prediction and analysis of SH2 domain-phosphopeptide interactionsM J Zvelebil, G Panayotou, J Linacre, et al.
Biochemical and Biophysical Research Communications|September 28, 1990
A molecular model for the enzyme cytochrome P450(17 alpha), a major target for the chemotherapy of prostatic cancerC A Laughton, S Neidle, M J Zvelebil, et al.
FEBS Letters|December 19, 1988
Predictions of linear T-cell and B-cell epitopes in proteins encoded by HIV-1, HIV-2 and SIVMAC and the conservation of these sites between strainsM J Zvelebil, M J Sternberg, J Cookson, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Idrugs : the Investigational Drugs Journal|May 10, 2008
Flavopiridol Hoechst AGM J Zvelebil
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prediction of protein structure from sequenceM J Sternberg, M J Zvelebil
Quarterly Reviews of Biophysics|August 1, 1993
Peptide-protein interactions: an overviewM J Zvelebil, J M Thornton
Protein Engineering|July 1, 1988
Analysis and prediction of the location of catalytic residues in enzymesM J Zvelebil, M J Sternberg
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
A detailed molecular model for human aromataseC A Laughton, M J Zvelebil, S Neidle
European Journal of Biochemistry|April 1, 1994
Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicalsM L Cunningham, M J Zvelebil, A H Fairlamb
Protein Engineering|February 1, 1991
A predicted three-dimensional structure of human cytochrome P450: implications for substrate specificityM J Zvelebil, C R Wolf, M J Sternberg
Protein Engineering|June 1, 1995
Prediction and analysis of SH2 domain-phosphopeptide interactionsM J Zvelebil, G Panayotou, J Linacre, et al.
Biochemical and Biophysical Research Communications|September 28, 1990
A molecular model for the enzyme cytochrome P450(17 alpha), a major target for the chemotherapy of prostatic cancerC A Laughton, S Neidle, M J Zvelebil, et al.
FEBS Letters|December 19, 1988
Predictions of linear T-cell and B-cell epitopes in proteins encoded by HIV-1, HIV-2 and SIVMAC and the conservation of these sites between strainsM J Zvelebil, M J Sternberg, J Cookson, et al.
Pageof 4